Table 5.
Histological type | n | ADC (×10 3mm2 s−1) 50–1000a,b, mean ± SD | ADC (×10 3mm2 s−1) 50, 1000c,a, mean ± SD | ADC (×10 3mm2 s−1) 200, 800c,b, mean ± SD | p-valuec | p-valuea | p-valueb |
---|---|---|---|---|---|---|---|
Ductal Ca in situ | 9 | 1.33 ± 0.70 | 1.35 ± 0.69 | 1.30 ± 0.76 | 0.68 | 0.31 | 0.95 |
Invasive ductal Ca | 47 | 1.05 ± 0.40 | 1.05 ± 0.40 | 1.06 ± 0.40 | 0.75 | 0.51 | 0.55 |
Lobular Ca in situ | 4 | 1.09 ± 0.19 | 1.10 ± 0.20 | 1.05 ± 0.20 | 0.07 | 0.14 | 0.07 |
Invasive lobular Ca | 20 | 1.30 ± 0.49 | 1.27 ± 0.45 | 1.30 ± 0.43 | 0.12 | 0.06 | 0.44 |
Mucinous Ca | 1 | 1.47 | 1.38 | 1.39 | _ | _ | _ |
Other malignantd | 8 | 1.21 ± 0.60 | 1.19 ± 0.60 | 1.23 ± 0.61 | 0.58 | 0.21 | 0.89 |
Fibroadenoma | 24 | 1.80 ± 0.36 | 1.78 ± 0.37 | 1.81 ± 0.38 | 0.46 | 0.32 | 0.77 |
Epithelial proliferative | 7 | 2.03 ± 0.39 | 2.00 ± 0.36 | 2.05 ± 0.36 | 0.06 | 0.18 | 0.87 |
Papilloma | 3 | 1.47 ± 0.11 | 1.45 ± 0.08 | 1.47 ± 0.09 | 0.11 | 0.59 | 1.00 |
Hamartoma | 2 | 1.85 ± 0.48 | 1.82 ± 0.43 | 1.92 ± 0.60 | 0.65 | 0.65 | 0.65 |
Other benigne | 13 | 1.71 ± 0.39 | 1.73 ± 0.39 | 1.70 ± 0.42 | 0.46 | 0.51 | 0.75 |
Ca, carcinoma; n, number of lesions; SD, standard deviation.
The p-value difference in mean ADC between ADCall and the pair 50, 1000 s mm−2 by lesion histological type (Wilcoxon test).
The p-value difference in mean ADC between ADCall and the pair 200, 800 s mm−2 by lesion histological type (Wilcoxon test).
The p-value difference in mean ADC between the pairs 50, 1000 and 200, 800 s mm−2 by lesion histological type (Wilcoxon test).
Not otherwise specified.
Fibrocystic changes, complex sclerosing adenosis, complex cystic lesion.